Index of Keywords
| Keyword | Pages |
|---|---|
| interferon-gamma receptor 1 | 001 |
| sarcoidosis | 001 |
| polymorphism. | 001 |
| disability | 009 |
| pain | 009 |
| quality of life | 009 |
| systemic sclerosis. | 009, 138 |
| anti-rankl | 022 |
| monoclonal antibody | 022 |
| rheumatoid arthritis | 022, 032, 095, 109 |
| treatment. | 022 |
| low-level laser therapy | 032 |
| knee joint | 032 |
| prednisolone | 032 |
| therapeutic ultrasound. | 032 |
| autoimmune systemic rheumatic diseases | 044 |
| covid-19 | 044 |
| disease course | 044 |
| prognostic factors. | 044 |
| cystatin c | 056 |
| disease activity | 056, 101 |
| juvenile lupus nephritis | 056 |
| renal biopsy | 056 |
| βeta-2 microglobulin. | 056 |
| lateral epicondylitis | 067 |
| platelet-rich plasma | 067 |
| ultrasound. | 067 |
| anxiety | 075 |
| covid-19 vaccines | 075 |
| rheumatic diseases | 075 |
| sars-cov-2. | 075 |
| adjuvant-induced arthritis | 082 |
| fibroblast-like synoviocytes | 082, 119 |
| lncrna xist | 082 |
| mir-34a-5p | 082 |
| yin yang 1. | 082 |
| saliva | 095 |
| screening. | 095 |
| muscle architecture | 101 |
| muscle strength | 101 |
| primary sjögren syndrome. | 101 |
| diagnostic biomarkers | 109 |
| single-cell rna-seq | 109 |
| t cells. | 109 |
| atl2 | 119 |
| inflammatory response | 119 |
| mir-30e-5p | 119 |
| rheumatoid arthritis. | 119 |
| apoptosis | 129 |
| bad | 129 |
| bax | 129 |
| flare | 129 |
| systemic lupus erythematosus. | 129 |
| dermatomyositis | 138 |
| inflammatory myopathies | 138 |
| myositis | 138 |
| polymyositis | 138 |
| ankylosing spondylitis | 148 |
| bone morphogenetic protein | 148 |
| dickkopf-1 | 148 |
| sclerostin. | 148 |